Información del artículo
Resumen
Los tumores müllerianos mixtos son neoplasias cuyo origen son las células estromales primitivas que originariamente derivan del mesodermo mülleriano. Reciben el nombre de mixtos porque están constituidos por elementos glandulares malignos y estromales sarcomatosos.
Sumary
Müllerian mixed tumours are neoplasms whose origins are primitive stromal cells, which are originally derived from the Mullerian mesoderm. They are called mixed because they are formed by malignant glandular elements and stromal sarcomatoses.
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.J. Sreenan, R.H. Willian.
Carcinosarcomas of the female genital tract.
Am J Surg Pathol, 19 (1995), pp. 666-674
[2.]
R.P. Colombi.
Sarcomatoid carcinomas of de female genital tract.
Semin Diagn Pathol, 10 (1993), pp. 169-175
[3.]
M.J. Costa, R. Khan, R. Judd.
Carcinosarcomas of the uterus and ovary. Correlation of clinical, pathologic and inmu-nohistochemical features in 29 cases.
Arch Pathol Lab Med, 115 (1991), pp. 583-590
[4.]
S.G. Silverberg, F.J. Major, J.A. Blessing, B. Fetter, F.B. Askin, S.Y. Liao.
Carcinosarcoma of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.
Int J Gynecol Pathol, 1 (1990), pp. 1-19
[5.]
L.L. Doss, A.S. Llorens, E.M. Henríquez.
Carcinosarcoma of the uterus: A 40 year experience from the state of Missouri.
Gynecol Oncol, 18 (1984), pp. 43-53
[6.]
G.M. García, R.G. Troyas, E.A. Bercero.
Mullerian adenosar-coma of the cervix.
Pathol Int, 45 (1995), pp. 890-894
[7.]
J. Lopez, J. Juan San.
Carcinosarcoma endometrial asociado a cistoadenocarcinoma seroso papilar de ovario.
Clin Invest Gin Obst, 26 (1999), pp. 268-271
[8.]
M. Braun, D. Wendler, W. Bersch, A. Heindenreich, H.P. Braum.
Primary paraurethral tumor (carcinosarcoma) of the vagina.
Urologe A, 37 (1998), pp. 382-385
[9.]
E. Sartori, L. Bazurini, A. Gadducci, F. Landoni, A. Lissoni, T. Maggino.
Carcinosarcoma of the uterus.
Gynecol Oncol, 67 (1997), pp. 70-75
[10.]
R.R. Nordall, G.B. Kristensen, A.E. Stewing, J.M. Nesland, E.O. Pet-tersen, C.G. Trope.
An evaluation of prognostic factors in uterine carcinosarcoma.
Gynecol Oncol, 67 (1997), pp. 316-321
[11.]
M. Medina, J.M. Silvan.
Carcinosarcoma ovárico.
Clin Invest Gin Obst, 26 (1999), pp. 313-314
[12.]
M.J. Costa, J. Vogelsan, L.J. Young.
p53 gene mutation in female genital tract tumors: a clinicopathologic study of 74 cases.
Mod Pathol, 7 (1994), pp. 619-627
[13.]
P.A. Nicotina, G. Ferlazo, A.M. Vincelli.
Proliferation indices and p53-inmunoccytochemistry in uterine mixed müllerian tumors.
Histol Histopathol, 12 (1997), pp. 967-972
[14.]
P.A. De Brito, S.G. Silverberg, J.M. Orenstein.
Carcinosarcoma malignant mixed müllerian of the female genital tract.
Hum Pathol, 24 (1993), pp. 132-142
[15.]
K. Ariyoshi, S. Kawauchi, T. Kaku, H. Nakano, M. Tsuneyoshi.
Prognostic factors in ovarian carcinosarcoma: a clinico-pathological and inmuno histochemical analysis of 23 cases.
Histopathology, 37 (2000), pp. 427-436
[16.]
Y. Iwasa, H. Haga, I. Konishi, Y. Kiobashi, K. Higuechi, E. katsuya-ma, et al.
Prognostic factors in uterine carcinosarcoma: a cli-nicopathologic study of 25 patiens.
Cancer, 82 (1998), pp. 512-519
[17.]
F. Guidozzi, T. Smith, A.B. Koller, L. Reinecke.
Management of uterine müllerian adenosarcoma with extrauterine metas-tatic deposits.
Gynecol Oncol, 77 (2000), pp. 464-466
[18.]
R. Soong, S. Knwles, I.G. Hamond, C. Michael, B.J. Iacopetta.
p53 protein overexpresion and gene mutation in mixed mülle-rian tumor of the uterus.
Cancer Detect Prev, 23 (1999), pp. 8-12
[19.]
E. Krishnan, R.E. Coleman.
Malignan mixed müllerian tumors of gy naecological origin: chemosensitive but agresive tumors.
Clin Oncol, 10 (1998), pp. 246-249
[20.]
T.H. Knocke, H.D. Weiymann, H. Kucera, H. Kolbl, B. Pokrajae, R. Potter.
Results of primary and adjuvant radiotherapy in the treatment of mixed müllerian tumors of the corpus uteri.
Gynecol Oncol, 73 (1999), pp. 389-395
[21.]
A. Rossi.
Carcinosarcoma arising in an endometrial polyp. Report of a case.
Pathologica, 91 (1999), pp. 282-285
[22.]
S. Fotiou, G. Hatjieleftheriou, G. Kyrousis, F. Kokka, N. Aposto-likas.
Long term tamoxifen treatment: et possible aetiological factor in the development of uterine carcinosarcoma.
Anticancer Res, 20 (2000), pp. 2015-2020
[23.]
M. Friederich, C. Villena, D.E. Mink, H. Bonkhoff, W. Smicht.
Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
Eur J Obst Gynecol Reprod Pathol, 82 (1999), pp. 85-87
[24.]
M.L. Carcangiu.
Uterine pathology in women with breast cancer treated with tamoxifen.
Pathologica, 89 (1997), pp. 223-233
[25.]
R. Meyberg, C. Villena, R. Axt, W. Smidt, M. Friederich.
He-terologus müllerian mixed tumor after whole body irradiation because of Hodgkin’s disease in stage IV.
Eur J Gynae-col Oncol, 21 (2000), pp. 160-163
[26.]
G.H. Eltabakh, R. Yadav.
Good response of malignant mixed müllerian tumor of the ovary to paclitaxel and cisplatin chemotherapy.
Eur J Gynaecol Oncol, 20 (1999), pp. 355-356
[27.]
C. Rebischung, P. Pautier, P. Morice, C. Jhomme, P. Duvillard.
Alpha-fetoprotein production by a malignant mixed mülle-rian tumor of the ovary.
Gynecol Oncol, 77 (2000), pp. 203-205
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
